Targeting cuproptosis in liver cancer: Molecular mechanisms and therapeutic implications
Apoptosis · 2025
DOI: 10.1007/s10495-025-02150-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Apoptosis, 2025. Verfasst von Yun-Fei Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, School of Stomatology, Henan University, Kaife…. Hauptthemen laut MEDLINE: Liver Neoplasms, Copper. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 225 Literaturangaben. Gefördert von: the Natural Science Foundation of Education Department of Henan Province, China.
Abstract (Originalsprache)
Liver cancer (LC) stands as one of the most prevalent and highly malignant tumors globally, with persistently elevated mortality rates. For advanced-stage LC, identifying efficacious treatment modalities remains a critical imperative. Cuproptosis, a newly identified form of regulated cell death, exhibits therapeutic potential for impeding LC progression. However, the current clinical evidence remains limited, meriting further in-depth investigation by researchers. Existing literature has summarized copper homeostasis, the molecular mechanisms of cuproptosis, and its roles in certain cancers. However, key challenges in clinical translation haven't been included in the research scope, such as the mechanistic complexity, poor targeting specificity, lack of mature biomarkers, and risk of therapeutic resistance. Notably, the lessons from failed clinical trials have not been fully integrated into ongoing investigations. This review systematically delineates cuproptosis-associated biomarkers in LC, critically analyzes the challenges of targeting cuproptosis for LC therapy and discusses potential solutions. By highlighting current research gaps, we aim to provide actionable research directions for future investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, School of Stomatology, Henan University, Kaifeng, 475004, Henan, China.
- School of Medicine, Henan University, Kaifeng, 475004, Henan, China.
- School of Basic Medical Sciences, Henan University, Kaifeng, 475004, Henan, China. 10190131@vip.henu.edu.cn.
- Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, School of Stomatology, Henan University, Kaifeng, 475004, Henan, China. jiangqiying365@126.com.
- School of Basic Medical Sciences, Henan University, Kaifeng, 475004, Henan, China. jiangqiying365@126.com.
- Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, School of Stomatology, Henan University, Kaifeng, 475004, Henan, China. ddwubiomed2010@163.com.
Förderung
- the Natural Science Foundation of Education Department of Henan Province, China
Zitieren
APA
Zhou, Y. F., Zhu, Y. W., Hao, M. Y., Li, H. J., Han, H. S., Li, Y. G., Si, W. R., Jiang, Q. Y., & Wu, D. D. (2025). Targeting cuproptosis in liver cancer: Molecular mechanisms and therapeutic implications. Apoptosis. https://doi.org/10.1007/s10495-025-02150-9
Vancouver
Zhou YF, Zhu YW, Hao MY, Li HJ, Han HS, Li YG, et al. Targeting cuproptosis in liver cancer: Molecular mechanisms and therapeutic implications. Apoptosis. 2025. doi:10.1007/s10495-025-02150-9
BibTeX
@article{Zhou2025,
author = {Zhou, Yun-Fei and Zhu, Yi-Wen and Hao, Meng-Yuan and Li, Hong-Jie and Han, Hang-Shen and Li, Yan-Ge and Si, Wei-Rong and Jiang, Qi-Ying and Wu, Dong-Dong},
title = {Targeting cuproptosis in liver cancer: Molecular mechanisms and therapeutic implications},
journal = {Apoptosis},
year = {2025},
doi = {10.1007/s10495-025-02150-9}
}
EUVIMED